Yes, THCA is legal in Switzerland under specific conditions, as it is not explicitly listed as a controlled substance under the Narcotics Act (Betäubungsmittelgesetz, BetmG). The Federal Office of Public Health (FOPH) permits THCA in hemp products containing ≤0.2% THC, aligning with EU regulations. However, products must avoid claims of psychoactive effects, as THCA’s conversion to THC could trigger compliance scrutiny.
Key Regulations for THCA in Switzerland
- THC Threshold: Products must not exceed 0.2% THC by dry weight, per FOPH guidelines. Trace amounts of THCA are tolerated if total THC remains compliant.
- Hemp Derivation: THCA must originate from EU-approved hemp strains (e.g., Cannabis sativa L.) listed in the Swiss Hemp Ordinance (Hanfverordnung).
- Marketing Restrictions: Advertising THCA as psychoactive or therapeutic without FOPH authorization violates the Therapeutic Products Act (Heilmittelgesetz, HMG).
Swiss authorities monitor THCA’s legal gray area closely, particularly as 2026 EU regulations tighten on novel cannabinoids. The FOPH may reclassify THCA if evidence emerges of its conversion to THC in consumer products. Producers must document sourcing and THC testing to mitigate enforcement risks.